This is likely true for samples with extreme methylation changes such as caused by mutation in a DNA methyltransferase (e.g. DNMT3A in an AML patient (60) or treatment with demethylating agents (61)). The gene discussed is DNMT3A; the disease is acute myeloid leukemia.